A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

United States

University of California, San Francisco (Data collection only), San Francisco, California

Children's Healthcare of Atlanta (Data Collection Only), Atlanta, Georgia

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York

Children's Hospital of Philadelphia (Data Collection Only), Philadelphia, Pennsylvania

Texas Children's Hospital (Data Collection), Houston, Texas

Children's Hospital of Wisconsin (Data Collection Only), Milwaukee, Wisconsin